Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.81 |
| ▸ | MAPT | P10636 | 4/20 | 0.81 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.63 |
| ▸ | CA9 | Q16790 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | HTR6 | P50406 | 6/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29871288 | 0.90 | GAA (1.00) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL109925 | 0.90 | GAA (1.00) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL29363328 | 0.90 | GAA (1.00) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL1732796 | 0.90 | GAA (1.00) | GAAMAPTCA2CA12CA1 | |
| Hydrochloric Acid SCHEMBL9447766 | 0.88 | GAA (0.96) | GAAMAPTCA2CA12CA1 | |
| Hydrochloric Acid SCHEMBL28556898 | 0.88 | GAA (0.96) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL28269760 | 0.88 | GAA (0.96) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL564676 | 0.87 | GAA (0.79) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL565259 | 0.87 | GAA (0.85) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL565062 | 0.87 | GAA (0.85) | GAAMAPTCA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106498803-A | A kind of paper grade (stock) sterilization antiseptic and preparation method thereof | 金福英 | 2017-03-15 | — | — | CN | claimed |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | CHECKMATE THERAPEUTICS INC. (KR) | 2026-01-22 | — | — | US | disclosed |
| WO-2023229346-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | 주식회사 체크메이트테라퓨틱스 | 2023-11-30 | — | — | WO | disclosed |
| WO-2023229346-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | 주식회사 체크메이트테라퓨틱스 | 2023-11-30 | — | — | WO | disclosed |
| US-10973831-B2 | Fluoropiperidine compounds as pure 5-HT 6 receptor antagonists | SUVEN LIFE SCIENCES LIMITED (IN) | 2021-04-13 | — | — | US | disclosed |
| US-10973831-B2 | Fluoropiperidine compounds as pure 5-HT 6 receptor antagonists | SUVEN LIFE SCIENCES LIMITED (IN) | 2021-04-13 | — | — | US | disclosed |
| CN-111051302-B | Fluoropiperidine compounds as pure 5-HT 6receptor antagonists | 苏文生命科学有限公司 | 2021-04-09 | — | — | CN | disclosed |
| EP-3649124-B1 | FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT6 RECEPTOR ANTAGONISTS | SUVEN LIFE SCIENCES LTD (IN) | 2021-03-03 | — | — | EP | disclosed |
| EP-3649124-B1 | FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT6 RECEPTOR ANTAGONISTS | SUVEN LIFE SCIENCES LTD (IN) | 2021-03-03 | — | — | EP | disclosed |
| US-20200155560-A1 | FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT 6 RECEPTOR ANTAGONISTS | SUVEN LIFE SCIENCES LIMITED (IN) | 2020-05-21 | — | — | US | disclosed |
| EP-0054230-A2 | Monoazo dyestuffs and use as image-forming dyestuffs in colour-photographic registration materials | Agfa-Gevaert AG (DE) | 1982-06-23 | — | — | EP | disclosed |
| US-4219473-A | Substituted unsymmetrical azo, azomethine 1:2 chromium complexes | CIBA-GEIGY CORPORATION (US) | 1980-08-26 | — | — | US | disclosed |
| US-4125368-A | Metallized monoazo dyes | TOMS RIVER CHEMICAL CORP. (US) | 1978-11-14 | — | — | US | disclosed |
| US-4086223-A | Asymmetrical 1:2-chromium complex azo dyestuffs | CIBA-GEIGY AG (CH) | 1978-04-25 | — | — | US | disclosed |
| US-4058408-A | Bis-benzoxazolyl-naphthalenes as optical brighteners | CIBA-GEIGY CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |
| US-4058515-A | Metallized phenyl-azo-naphthol compounds | TOMS RIVER CHEMICAL CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |
| US-4053462-A | UNSYMMETRICAL PHENYL AZO NAPHTHYL CHROMIUM COMPLEX DYES | CIBA-GEIGY CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
| US-4005065-A | GOOD FASTNESS TO LIGHT, PERSPIRATION, FULLING, DECATIZING AND CARBONIZING | CIBA-GEIGY CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-3993659-A | Bis-benzoxazolyl-naphthalenes as optical brighteners | CIBA-GEIGY CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3985763-A | DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200155560-A1 | FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT 6 RECEPTOR ANTAGONISTS | HTR6, HTR5A, HTR1B | GAA 3728/4885MAPT 2944/4885CA2 3947/4885 |
| US-10973831-B2 | Fluoropiperidine compounds as pure 5-HT 6 receptor antagonists | HTR6, HTR5A, HTR1B | GAA 3728/4885MAPT 2944/4885CA2 3947/4885 |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | NAMPT, NAPRT, NNT | GAA 2409/4885MAPT 1402/4885CA2 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.